Value Bridge — CHEROKEE MEDICAL CENTER
Current $5M → Target $6M (+$1.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$5.1M
Current EBITDA
$6.4M
Target EBITDA
+$1.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.3M
Payer Mix Optimization
$0.7M
Cost to Collect Reduction
$0.2M
Clean Claim Improvement
$0.2M
Volume & Rate Growth
$1.2M
What This Means
The 7-lever model projects a 27% EBITDA uplift from $5M to $6M. The highest-impact lever is Volume & Rate Growth at $0.5M probability-weighted.
IC talking point: "We see $1M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $15M in equity value creation."